Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Lebel-Shostak (Petah-Tikva, Israel), B. Pertzov (Petah-Tikva, Israel), O. Grossberger (Petah-Tikva, Israel), D. Rosengarten (Petah-Tikva, Israel), D. Shitenberg (Petah-Tikva, Israel), M. Heshing (Petah-Tikva, Israel), S. Amor (Petah-Tikva, Israel), M. Kramer (Petah-Tikva, Israel). The use of mTOR inhibitors is associated with improved survival in lung transplant recipients. 4724

Member's Comments

No comment yet.

Related content which might interest you: Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Evaluation of the biological effects of atorvastatin in lung transplant recipients Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004 Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports Source: Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019 Year: 2020 Rapamycin in patients with chronic lung rejection Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Metformin improves survival in lung cancer patients receiving EGFR-TKIs therapy> Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Polymorphisms in immunosuppression transporters affect outcome after lung transplantation. Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Pre-habilitation in lung transplant candidates Source: Short video discussion 2021 Year: 2021 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Predictors of survival of patients waiting for lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Gefitinib in the non small cell lung cancer treatment: contribution to prolongation and quality of survival Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004 Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Calcineurin inhibitors do not affect the expansion of CD4+CD25+ Treg cells in peripheral blood of lung transplant recipients Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006 How to improve long-term outcomes following lung transplantation Source: International Congress 2019 – Lung transplantation in 2019: where are we? Year: 2019 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival Source: ERJ Open Res, 6 (2) 00003-2020; 10.1183/23120541.00003-2020 Year: 2020 Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019